SNUBI Research :: SysBiol  (838 talks)
All  Seminar  BioEMR  xMutant  SysBiol  MAInfo  J.Club  TopicSem  BookReading    This week    New Talks   Old SysBiol page    Help

ADD NEW USER

Go to team wiki page
Goal
  • Deciphering personal genomes

    • Date
  • Weekly meeting : every Monday, 11:00

    • Members
  • 조민아, 부은경, 안세환, 전예진, 임성수, 이시은

    • 팀:   발표자:    제목/키워드:    날짜:   

    2024-09:
    09 전예진 MR 

    2024-08:
    05 임성수 Predict anti-cancer drug response by using alternative splicing-based gene pairs 

    2024-04:
    08 임성수 Identification of novel pairwise biomarkers to predict and treat cancer metastasis  

    2024-02:
    19 전예진 the use of two sample methods for MR on single large datasets 
    26 임성수 Identification SAM pairs from TCGA dataset 

    2024-01:
    15 이시은 G-CDM : genomic information to current OMOP-CDM 
    22 조민아 Comparison between matching and sex exact matching 

    2023-12:
    23 전예진 DGIdb ; new Query Score and updated Interaction Score 

    2023-11:
    13 임성수 Identifying synthetic anti-metastasis pairs from TCGA dataset - external validation 
    27 조민아 Workflow of extracing eid considering self-report 

    2023-10:
    16 조민아 AACR-KCA poster: Gene signatures for prediction of survival in bladder cancer patients treated with immune checkpoint inhibitor 

    2023-09:
    18 임성수 Identifying SAM pairs from TCGA dataset 

    2023-08:
    07 임성수 Identifying SAM pairs - calculate GVB by defining LOF mutations 
    21 조민아 Code for network analysis of pair-wide gvb  

    2023-07:
    03 임성수 Identifying SAM pair from TCGA-SKCM 
    10 조민아 Code of trend of GVB in m-core analysis 

    2023-06:
    05 조민아 igraph: r package for network graph (code)  
    05 조민아 igraph: r package for network graph (code)  
    05 조민아 igraph: r package for network graph (code)  

    2023-05:
    15 임성수 (Replication) Identifying SAM pairs from TCGA-COAD patients 

    2023-04:
    02 임성수 (Replication) Overall process of identifying SAM gene pairs from TCGA 
    17 조민아 Downloading data using pyega3 

    2023-03:
    27 전예진 pgx-passport 

    2023-02:
    13 조민아 RNA-seq deconvolution 

    2023-01:
    05 안세환 test    

    2022-12:
    26 전예진 FoldX_variant stability and effect prediction 

    2022-11:
    21 조민아 SCISSOR: tutorial 

    2022-10:
    03 ... 개천절 
    10 ... 대체휴일 
    17 조민아 All variants of CEMIP2 genes in ulcerative colitis patients 
    24 부은경 . 

    2022-09:
    26 전예진 type of pharmacogenomic evidence and limitation 

    2022-08:
    01 조민아 Application of long-read sequencing to elucidate complex pharmacogenomic regions: a proof of principle 

    2022-07:
    18 안세환 Adjusted Rand Index between haplogroups and populations  

    2022-06:
    20 안세환 Evaluate the haplogrouping method by DNA evolution pairwise distances 
    27 조민아 Euclidean distance-optimized data transformation for cluster analysis in biomedical data (EDOtrans) 

    2022-05:
    16 안세환 Summary of variants in 25 pharmacogenes 
    23 조민아 JASPAR database: an open-access database of curated, non-redundant transcription factor (TF) binding profiles 

    2022-04:
    05 부은경 Exploration of genotype-phenotype interactions and prevalence of genetic variants 
    25 조민아 The complete sequence of a human genome (github) 

    2022-03:
    29 조민아 Comparing coverage of genotyping of previous study 

    2022-02:
    22 조민아 Extracting disease age of onset in UKBB 

    2022-01:
    11 조민아 Genozip: a universal extensible genomic data compressor 
    18 부은경 Case study of thiopurine intolerance in IBD  

    2021-12:
    07 조민아 The UKBB clinical data of results in UC patients group 
    14 부은경 Study ideas for analyzing recurrent event data and correcting potential bias 
    28 안세환 TPMT star-alleles in high-coverage T1GP 

    2021-11:
    02 부은경 Analysis of rare and ultra-rare variants in gene based tests 
    23 안세환 Comparison of phasing strategies for whole human genomes 

    2021-10:
    05 조원일 genetic correlation 
    12 안세환 Segmented haplotype estimation and imputation tools (SHAPEIT4) 
    12 안세환 Segmented haplotype estimation and imputation tools (SHAPEIT4) 
    19 윤미선 A Benchmark Dataset for Automatic Segmentation and Labeling of Individual Ribs on Chest X-rays 
    26 조민아 Liftover using r package, rtracklayer 

    2021-09:
    28 부은경 Comparison of TIL incidence rate in combined IBD dataset 

    2021-08:
    03 조민아 The CCGWAS R package : a tool for case-case association testing of two different disorders based on their respective case-control GWAS results 
    10 부은경 Survival Analysis Using Frailty Models 
    17 조원일 genetic correlations of polygenic disease traits 
    24 안세환 TPMT star-alleles and haplogroups of Health Showcase data 

    2021-07:
    06 안세환 Querying against cell viability data(PRISM) in CMap LINCS website 
    20 윤미선 Group-based pharmacogenetic prediction 
    27 김주연 Comparing distribution of variants in PD genes among 1KGP3 populations 

    2021-06:
    01 윤미선 Stargazer genotyping 
    08 김주연 Revised association between PGx haplotype frequency and drug use in the UKBB population 
    15 조민아 Review: Benchmarking the Human Leukocyte Antigen Typing Performance of Three Assays and Seven Next-Generation Sequencing-Based Algorithms 
    29 조원일 Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data 

    2021-05:
    04 조동영 Pharmacogenomics Application and Challenges 
    04 조동영 Pharmacogenomics Application and Challenges 
    11 유경훈 Opportunities and challenges for the computational interpretation of rare variation in clinically important genes 

    2021-04:
    08 조민아 Review: Transfer learning enables prediction of CYP2D6 haplotype function 
    13 부은경 A systematic comparison of pharmacogene star allele calling bioinformatics algorithms: a focus on CYP2D6 genotyping 
    20 조원일 Review: Pharmacogenimics_lancet 
    20 조원일 Review: Pharmacogenimics_lancet 
    20 조원일 Review: pharmacogenomics_lancet 
    27 안세환 Calling star-alleles from NGS data 

    2021-02:
    18 홍진희 ukbb genotype 
    18 홍진희 ukbb genotype 
    18 홍진희 ukbb genotype 

    2021-01:
    07 유경훈 Global distribution of CYP2C19 risk phenotypes affecting safety and effectiveness of medications 
    14 홍진희 manual of using GP dataset in ukbb 

    2020-12:
    03 김주연 Refining the clinical definition of clopidogrel adverse events 
    17 조민아 PHASE: A program for reconstructing haplotypes from population data 

    2020-11:
    05 조민아 Introduction of Taiwan biobank database 
    05 조민아 Introduction of Taiwan biobank database 
    12 부은경 FastTargetPred: a program enabling the fast prediction of putative protein targets for input chemical databases 
    14 조민아 Review: Neutrophil-to-lymphocyte ratio in inflammatory bowel disease - as a new predictor of disease severity 
    17 조민아 All variants of CEMIP2 genes in ulcerative colitis patients 
    17 조민아 All variants of CEMIP2 genes in ulcerative colitis patients 
    17 조민아 Downloading data using pyega3 
    17 조민아 Downloading data using pyega3 
    17 조민아 Downloading data using pyega3 in python 

    2020-10:
    22 김주연 Primary care prescription drug use and related actionable drug-gene interactions in the Danish population 

    2020-08:
    31 김주연 Identifying populations likely to benefit from pharmacogenomic testing 

    2020-07:
    06 박유미 Genotype Data in UKBiobank 
    13 김주연 The implementation of pharmacogenomics for older adults 
    23 홍진희 synthetic association study 
    23 홍진희 synthetic association study 
    23 홍진희 synthetic association study 
    23 홍진희 synthetic association study 
    23 홍진희 synthetic association study 
    23 홍진희 synthetic association study 
    23 홍진희 synthetic association study 
    23 홍진희 synthetic association study 
    23 홍진희 synthetic association study 
    23 홍진희 synthetic association study 
    27 조민아 Gene set enrichment analysis tools 

    2020-06:
    01 부은경 Additional analysis to identify candidate variants associated with PD 
    08 안세환 Mechanism of action lists in L1000 data 
    15 한봄 Assessment of case-control studies 

    2020-05:
    04 박유미 COVID-19 data in the UK Biobank 
    11 김주연 Contribution of genetic variation in drug-drug-gene-interactions 
    11 김주연 Contribution of genetic variation in drug–drug–gene interactions 
    18 홍진희 illumina sequencing WES 111 samples 
    25 조민아 Association analysis-Plink and Snpsift 

    2020-04:
    06 안세환 The Comparative Toxicogenomics Database 
    13 한봄 The utility of surrogate markers in predicting HLA alleles associated with adverse drug reactions in Vietnamese 
    20 최선 Database for screening the toxicity of peptides 
    27 김효정 [review] Development of a Genomic Data Flow Framework: Results of a Survey Administered to NIH-NHGRI IGNITE and eMERGE Consortia Participants 

    2020-03:
    02 박유미 Comparing polygenic risk scores between male and female depressive patients 
    09 김주연 The design and implementation strategy of European pharmacogenomics through the U-PGx consortium 
    09 김주연 The design and implementation strategy of European pharmacogenomics through the U-PGx consortium 
    19 홍진희 Whole exome seuqence varinat calling in 2 ALL patient    
    19 홍진희 Whole exome seuqence varinat calling in 2 ALL patient 
    19 홍진희 Whole exome seuqence varinat calling in 2 ALL patient 
    23 조민아 Preprocessing WES data of EOAD (Early Onset Alzheimer’s Disease) 
    23 조민아 Preprocessing WES data of EOAD (Early Onset Alzheimer’s Disease) 
    23 조민아 Preprocessing WES data of EOAD (Early Onset Alzheimer’s Disease) 
    30 부은경 Variants associated with PD 

    2020-02:
    24 김효정 [Review] Personalized Medicine and the Power of Electronic Health Records 
    24 김효정 [Review] Personalized Medicine and the Power of Electronic Health Records 

    2020-01:
    06 부은경 Synergyfinder: Calculate and Visualize Synergy Scores for Drug Combinations 
    13 안세환 Visualize interpretable pattern from LINCS-L1000 
    20 한봄 HLA*IMP 

    2019-12:
    02 김효정 [Review] The Role of Modeling in Clinical Information System Development Life Cycle 
    09 박유미 The GenomeAsia 100K Project enables genetic discoveries across Asia 
    16 김기태 Identifying genes related to age of onset in Major Depressive Disorder (MDD) patients 
    23 김주연 Examination of Parkinson’s disease cSAG deleteriousness using GVB score and pathway analysis 

    2019-11:
    11 안세환 Introduction to Genetic Algorithm 
    25 유경훈 Towards precision medicine: interrogating the human genome to identify drug pathways associated with potentially functional, population-differentiated polymorphisms 

    2019-10:
    14 박유미 Distribution of in silico prediction scores for NUDT15 variants identified in gnomAD database 
    21 김기태 Analysis of OPLL 
    28 김주연 Evaluation of candidate SAGs using tacrolimus sample WXS data 

    2019-09:
    02 김기태 OPLL analysis  
    09 김주연 Candidate SAG evaluation using tacrolimus sample data 
    16 안세환 Subtype of Cell Lines in L1000 data 
    23 한봄 Biomarkers of adverse drug reactions 
    23 한봄 Biomarkers of adverse drug reactions 
    30 유경훈 Pharmacogenomic genotypes define genetic ancestry in patients and enable population-specific genomic implementation 

    2019-08:
    12 박유미 Whole-genome sequencing of rare disease patients in a national healthcare system - Genomics England 100,000 genomes project 
    12 유경훈 Standardized Biogeographic Grouping System for Annotating Populations in Pharmacogenetic Research    
    26 김효정 [review] Genomic information for clinicians in the EHR: lessons learns from clinGen and eMerge 

    2019-07:
    01 박유미 Association of CRIM1 variant and 6-mercaptopurine-induced adverse effects in childhood acute lymphoblastic leukemia 
    01 유경훈 Hubble2D6: A deep learning approach for predicting drug metabolic activity 
    08 김기태 Analysis of age at onset in depression 
    15 김주연 ADR related synthetic association study: data processing flow and statistics 
    22 안세환 The GCTx format and cmap{Py, R, M, J} packages: resources for optimized storage and integrated traversal of annotated dense matrices 

    2019-06:
    03 안세환 Errors in importing Leukemia Data 
    10 한봄 Read quality check using CaReal 
    24 김효정 [Review] Standardizing terms for clinical pharmacogenetic test results: consensus terms from the CPIC 

    2019-05:
    13 박유미 Evaluating potential drug targets through human loss-of- function genetic variation 
    20 김기태 Parallel processing in R  
    27 김주연 Candidate SAG interpretation based on inter-ethnic variability 

    2019-04:
    08 김주연 A disease-drug database to support drug prescribing based on patient pharmacogenomics test results 
    15 안세환 Select available columns in cBioPortal mutation file 
    22 한봄 Definitions of HLA typing terms 
    22 한봄 Definitions of HLA typing terms 
    30 유경훈 Clinical use of current polygenic risk scores may exacerbate health disparities 

    2019-03:
    07 안세환 File Formats for cBioPortal 
    18 김효정 Assessment of serologic markers on liver fibrosis: descriptive statistics 
    25 박유미 An open resource of structural variation for medical and population genetics 
    25 유경훈 DGIdb 3.0: a redesign and expansion of the drug-gene interaction database 

    2019-02:
    07 김기태 Consensus Path DB 
    14 김주연 Evaluation of synthetic association detection using gene deleteriousness scores in hearing loss case 
    28 한봄 Marker selection for genetic case-control association studies 

    2019-01:
    03 한봄 Data quality control in genetic association studies 
    10 유경훈 Drug Targetor: a web interface to investigate the human druggome for over 500 phenotypes 
    17 이정훈 Combination chemotherapy in advanced gastric cancer 
    24 김효정 Assessment of Diagnostic Usefulness of Liver Fibrosis Predictive Markers  
    31 박유미 Difference of genetic architectures in men and women with depression 

    2018-12:
    06 김기태 Analysis of Early response in depression 
    13 김주연 ITPA gene variants protecting against anemia as a case of synthetic association 
    20 안세환 Protein domain layer in VVA Plot 

    2018-11:
    08 유경훈 Analysis of population-specific pharmacogenomic variants using next-generation sequencing data 
    15 이정훈 ConnectivityMAP database in CLUE portal 
    22 김효정 Query design strategy for detecting NSAIDs induced ADRs  
    29 박유미 Descriptive data analysis: in vitro functionality of 337 PGx variants 

    2018-10:
    04 박유미 Translating genotype data of 44,000 biobank participants into clinical pharmacogenetic recommendations: challenges and solutions 
    11 김기태 Geneset Deleterious Burden Analysis (GS-DBA) 
    18 김주연 Characteristics of candidate SAGs with regard to ethnicity 
    25 안세환 The Cochran-Armitage Trend Test(CATT) in result table of VVA 

    2018-09:
    06 한봄 Study of Glucocorticoid-Induced Diabetes Mellitus 
    13 이정훈 TP53 Paclitaxel SC Network is Prognostic Factor on Urogenital Cancers 
    20 유경훈 Integrating rare genetic variants into pharmacogenetic drug response predictions 
    27 김효정 GDM DB migration to NGS server 
    27 김효정 GDM DB migration to NGS server 

    2018-08:
    02 박유미 Worldwide Distribution of Cytochrome P450 Alleles 
    09 김주연 Using TCGA for validation of synthetic association  
    16 김기태 Age of onset in MDD 
    23 안세환 Add knowledge bases to VVA plot 

    2018-07:
    05 유경훈 Interpretation of genes related to early response by antidepressant group 
    12 이정훈 NGS biomarker for busulfan ADR 
    12 이정훈 NGS biomarker for busulfan ADR 
    19 한봄 Steroid Induced Hyperglycemia 
    26 김효정 [review] A standard database for drug repositioning 

    2018-06:
    07 박유미 Current progress and future prospects in organoid research 
    21 김주연 Signatures and examples of synthetic association 
    21 김주연 Signatures and examples of synthetic association 
    28 안세환 Apply VVA to GDM 

    2018-05:
    03 한봄 Tumor-only analysis on rare cancer samples 
    10 안세환 Knowledge Bases for VVA 
    17 유경훈 Review: Ki Database 
    24 이정훈 A Next Generation Connectivity-Map L1000 for drug treatment profiles 
    31 김효정 TCGA Clinical Data Structure Review  

    2018-04:
    05 박유미 Functionalization of Variants in Clinically Actionable Pharmacogenes (F-CAP) 
    12 김효정 Exploratory analysis: KAERS dataset  
    19 김기태 Analysis of onset age in depression 
    19 김기태 Analysis of onset age in depression_meet 
    26 김주연 Evaluation of extracting genes with variants in synthetic association to ADR biomarkers 

    2018-03:
    08 안세환 VVA review and future work 
    08 안세환 VVA review and future work 
    08 안세환 VVA review and future work 
    15 한봄 Tumor-only analysis on rare cancer samples 
    22 유경훈 Sub-group of SIOH patient groups according to drug response record. 
    29 이정훈 RS-ADR data portal development, Firebase & vue.js 

    2018-02:
    08 이정훈 The comparative analysis of the gene regulatory network according to the pathological stages reveals the characteristics of metastasis in gastric cancer 
    14 류영재 PharmVar database overview 
    14 류영재 PharmVar database overview 
    14 류영재 PharmVar database overview 
    28 김주연 Interpretation of genes in synthetic association to PGx variants: a case study 

    2018-01:
    11 김주연 Pathway annotation of genes synthetically associated to GWAS PGx variants 
    18 이정훈 Synthetic Dosage Cytotoxicity for prioritization of chemotherapy 
    31 김주연 Pathway enrichment analysis for FDA and GWAS PGx variants 

    2017-12:
    07 이정훈 Non-linear model to predict cytotoxic drug response 
    14 김주연 Gene set annotation for genes synthetically associated with PGx variants 
    28 박호경 1265 Potential drug targets gene 

    2017-11:
    02 박호경 SSRIs drugs with Pharmacogenomic snp and adr 
    09 이정훈 K-CDM: Conversion of EMR data to OMOP format 
    16 김주연 Using standard queries to analyze ADR risks across multiple institutions 
    16 김주연 Using standard queries to analyze ADR risks across multiple institutions 
    23 류영재 PharmCAT review 
    30 박호경 druggable proteome classification and examples 

    2017-10:
    09 이정훈 Korean Clinical Imaging Guidelines and clinical decision support system 
    16 김주연 Variant level analysis of genes in synthetic association to PGx variants: case for rs4646244 TA, AA 
    16 김주연 Variant level analysis of genes in synthetic association to PGx variants: case for rs4646244 TA, AA 
    26 류영재 Extracting information from PharmGKB 

    2017-09:
    11 김주연 Extracting variants associated to drug response from the NHGRI GWAS Catalog 
    18 류영재 DMET data processing protocol 
    25 박호경 SNRIs Antidepressants and Pharmacogenomic information 
    25 박호경 SNRIs Antidepressants and Pharmacogenomic information 

    2017-08:
    07 김주연 Results of predominant and synthetically associated genes to PGx alleles 
    07 김주연 synthetic association study 
    07 김주연 synthetic association study 
    07 김주연 synthetic association study 
    07 김주연 synthetic association study 
    28 박호경 Most-Prescribed Antidepressants - Mental Health Daily report 

    2017-07:
    03 김주연 Updated statistics for determining ADR risk according to PGx variant status using synthetic association 
    10 류영재 Chemotherapy and adverse drug reactions in Acute Myeloid Leukemia  
    17 박지혜 SCAN and PACdb : pharmacogenomics databases 
    17 박지혜 SCAN and PACdb : pharmacogenomics databases 
    24 박호경 Tricyclic antidepressants and similarity of interacting genes 
    31 이정훈 Finding genes targeted by GDSC drugs 

    2017-06:
    05 박지혜 Repositories where researchers can download or upload genomic data 
    12 류영재 Roles of Solute Carriers and the functional consequences of polymorphism 
    19 박호경 Tricyclic antidepressants physiologic action and ADR 
    26 이정훈 A tool for discovering drug sensitivity and gene expression associations in cancer cells 

    2017-05:
    01 류영재 Roles of ATP-Binding Cassette transporters and the functional consequences of polymorphism 
    15 박호경 P-glycoprotein polymorphism and drug adverse response 
    29 김주연 ADR risk according to 8 PGx variant statuses using synthetic association 

    2017-04:
    03 박지혜 ePGA: AWeb-Based Information System for Translational Pharmacogenomics 
    10 박호경 Pharmacogenetics of Membrane Transporters ABCB1 
    17 이정훈 Gastric cancer metastasis network analysis 
    24 김주연 Statistics of updated PGx variants for synthetic association analysis 

    2017-03:
    06 이정훈 Weakly supervised learning 
    13 김주연 Visualization of variants grouped by genes in synthetic association with PGx variants 
    20 이계화 Review Cases of Genomic Data Warehouse  
    27 류영재 Effects of variants in transporter genes on drug efficacy and toxicity  

    2017-02:
    06 홍주영 Transporter-madiated drug-drug interactions 
    23 류영재 Effects of variants in transporter genes on drug efficacy and toxicity 
    27 박호경 Detecting Antibiotic Resistance Genes 

    2017-01:
    02 박지혜 The Use of Gene Ontology Term and KEGG Pathway Enrichment for Analysis of Drug Half Life 
    02 박지혜 The Use of Gene Ontology Term and KEGG Pathway Enrichment for Analysis of Drug Half Life 
    09 박호경 PharmGKB Clinical annotation search 
    16 이정훈 Inference cancer drug prognosis via cell line model 
    23 김주연 Chromosomal distribution of variants synthetically associated with pharmacogenomic SNPs 

    2016-12:
    05 이정훈 Integrative analysis for identifying the best anticancer therapy based on genomic features 
    12 김주연 Determining adverse drug event risk according to FDA SNP genotype 
    12 김주연 Determining adverse drug event risk according to FDA SNP genotype 
    12 김주연 Determining adverse drug event risk according to FDA SNP genotype 
    12 김주연 Determining adverse drug event risk according to FDA SNP genotype using synthetic association 
    19 홍주영 [DDGI DB] TRANSFORMER 
    26 류영재 SFINX database 

    2016-11:
    07 홍주영 Human BioPathway Databases 
    07 홍주영 Results of predominant and synthetically associated genes to PGx alleles 
    14 류영재 DMET data processing protocol 
    21 박지혜 Review of BRENDA database 
    27 박호경 drug side effects information – ex Metformin 

    2016-10:
    03 류영재 SFINX database 
    10 박지혜 validation result of PharmSafe by variant score filter 
    17 박호경 Bina - develops next-generation genomic management  
    19 박호경 Mutual exclusive network and inference target from drug sensitivity 
    19 박호경 Mutual exclusive network and inference target from drug sensitivity 
    19 박호경 Mutual exclusive network and inference target from drug sensitivity  
    31 김주연 Results of variant-centric approach for MRONJ 
    31 김주연 Human BioPathway Databases 

    2016-09:
    12 이계화 Gender Difference in ADR - Review of Article (Systematic Analysis of Adverse Event Reports for Sex Differences in Adverse Drug Events, 2015, Scientific Report)  
    19 김주연 Risk for ADEs in South Korean geriatrics from Beers Criteria medications 
    26 홍주영 Physiologically Based Pharmacokinetic Modeling 
    9 이정훈 WGCNA Network analysis of Microarray data 

    2016-08:
    01 김주연 Distribution of F10 mutations in the 1000 Genomes phase 3 population 
    08 홍주영 Knowledge based Pharmsafe Database 
    15 unknown 광복절 
    15 류영재 Exome Sequencing Project 
    29 박호경 Cloud Platform - Pricing 

    2016-07:
    04 박지혜 MetaCyc database review 
    11 박호경 TB database 
    18 한지예 Pharmacoinformatics tools in Drug discovery and Development activities. 
    25 이정훈 Microarray analysis (Illumina), research results 

    2016-06:
    06 이정훈 Intratumor heterogeneity influences the interaction of neoplastic cells with ECM proteins 
    13 김주연 Detecting candidate variants of MRONJ occurrence 
    20 홍주영 The UCSF-FDA TransPortal 
    27 류영재 Therapeutic Targets Database review 

    2016-05:
    02 홍주영 Pharmsafe Application 
    09 류영재 [Review] DSigDB 
    16 박지혜 20 Most frequently prescribed therapeutic classes : National Ambulatory Medical Care Survey - CDC 
    23 박호경 genotype and HIV drug 
    30 한지예 PGRN/PGX tool and Drug Metabolizing Enzymes (DMEs) among Different Population 

    2016-04:
    04 박호경 HER2-positive breast anticancer drug and genotype 
    11 한지예 Ethical, social and legal issues in pharmacogenomics    
    18 이정훈 Identification of Drug relative genes predictive of Cancer survival in Chemotheraphy agent 
    25 김주연 CNV and gene expression profile in 1000 Genomes phase 3 population 
    25 김주연 CNV and gene expression profile in 1000 Genomes phase 3 population 
    25 김주연 Association between CNV and gene expression using 1000 Genomes data 
    25 김주연 Copy number variation and gene expression in 1000 Genomes phase 3 population 
    25 김주연 Association between CNV and gene expression using 1000 Genomes data 

    2016-03:
    01 이정훈 DGIdb Database review and research examples 
    08 김주연 Review of very important pharmacogenes in PharmGKB 
    14 홍주영 pharmsafe report review 
    21 류영재 DrugBank XML structures and parsing 
    21 류영재 DrugBank XML structures and parsing 
    28 박지혜 Database Review : SuperTarget 

    2016-02:
    02 이계화 BRONJ gene centric analysis 
    09 박지혜 Integration of DrugBank and KEGG 
    16 박호경 cmap data and perturbation sensitivity 
    23 한지예 CYP450 and Personalized Medicine using 1000 genomes  

    2016-01:
    05 류영재 PharmPortal Updated Database Schema 
    12 박지혜 Discussion about validation of PK weighted drug score 
    19 김주연 Model on predicting patients likely to benefit from preemptive genotying 
    26 류영재 PharmSafe Report calculations 

    2015-12:
    15 김주연 Review of clinical outcomes from pharmacogenotyping 
    22 류영재 Fine-tuning plans 
    29 김주연 Indications and pharmacologic action of frequently prescribed drugs in US and South Korea 

    2015-11:
    03 김주연 Review of pharmacoeconomic analysis methods 
    24 김주연 Application of breakeven analysis for preemptive genotyping 

    2015-10:
    13 김주연 Review of pharmacogene-related ADRs in Koreans 

    2015-09:
    01 김주연 Distribution of drug usage extent in HIRA 2011 patients 
    22 김주연 Overview of Korea Adverse Event Reporting System 

    2015-08:
    04 류영재 Core functions of PharmPortal 
    11 김주연 Trend in predicted number of people with serious AE over year 2011 
    18 박지혜 Statistics of input drug-gene pair with Km and Kcat 

    2015-07:
    07 김주연 Refined figures for patient demographics and calculation results of preemptive PG study 
    11 김주연 Refined figures for patient demographics and calculation results of preemptive PG study 
    28 김주연 Progress of figures on number of patients predicted to have AEs based on genotype 

    2015-06:
    16 김주연 Additional results of preemptive genotyping calculation algorithm using 1KP ancestry 
    16 김주연 Additional results of preemptive genotyping calculation algorithm using 1KP ancestry 

    2015-05:
    06 김주연 Calculation workflow for showing need for preemptive genotyping  
    26 김주연 Calculation scheme for predicting number of people with adverse events using ancestry-weights 

    2015-02:
    17 김주연 Statistics of processed year 2011 HIRA data 

    2015-01:
    06 김주연 Comparison of statistics for inpatient and outpatient prescriptions of year 2011 
    27 김주연 Overview of HIRA 2011 statistics 

    2014-12:
    16 김주연 Statistics of year 2011 HIRA data and PREDICT study data 
    16 김주연 Statistics of year 2011 HIRA data and PREDICT study data 

    2014-11:
    11 류영재 DMET data processing protocol 
    11 류영재 DMET data processing protocol 
    11 류영재 DMET data processing protocol 
    11 류영재 DMET data processing protocol 
    25 김주연 Calculating number of preventable adverse events with HIRA data using PREDICT algorithm 

    2014-10:
    22 김주연 Statistics of year 2011 HIRA patient and drug data 

    2014-09:
    11 백수연 Busulfan case reports of identifited ADR associated gene with personal genome sequence 
    18 류영재 Drug Transporters in Drug Efficacy and Toxicity Review 
    18 류영재 Drug Transporters in Drug Efficacy and Toxicity Review 
    18 류영재 Drug Transporters in Drug Efficacy and Toxicity Review 
    24 김주연 Calculation of number of potential adverse events prevented from preemptive genotyping-meta analysis process 
    24 김주연 Calculation of number of potential adverse events prevented from preemptive genotyping-meta analysis process 

    2014-08:
    05 백수연 Discussion about case study result of ADR related gene detection 
    12 류영재 Therapeutic Targets Database review 
    19 김주연 Examination of number of preventable adverse events using PREDICT algorithm and HIRA drug claims data 
    26 김주연 Review of Iodine website 
    31 김주연 Review of the roles and mechanisms of proteins encoded by pharmacogenes 

    2014-07:
    01 김주연 Examination of number of patients prescribed drugs with clinically severe AEs modulated by variant alleles 
    08 박지혜 Discussion about weight score of drug-gene pair without Km value 
    15 백수연 systemetic validation result of ADR gene detection 
    15 백수연 systemetic validation result of ADR gene detection 
    15 백수연 CNV and gene expression profile in 1000 Genomes phase 3 population 
    22 김주연 Examination of the frequency of pharmacogenetic medication prescribing in Korea 
    22 김주연 Examination of the frequency of pharmacogenetic medication prescribing in Korea 
    29 박지혜 Discussion about results of weighted drug score (log transformation) 

    2014-06:
    03 백수연 Discussion of validation result of ADR causal gene detection 
    10 김주연 Review of FDA-approved drugs with pharmacogenomic information in their labeling 
    17 박지혜 Discussion about validation set of Km weighted drug score 
    24 백수연 Discussion of validation result of ADR causal gene detection 

    2014-05:
    07 박지혜 Compare the result calculating weighted drug score using Km mean value and Km median value 
    13 백수연 Review and cleansing of DITOP database 
    20 김주연 Examination of data in Korea Health Insurance Review & Assessment Service 
    27 박지혜 Discussion for weight score of Km value 

    2014-04:
    01 백수연 Discuss the result of pharmacodynamic sub-module construction related to ADR 
    08 김주연 Review of Cancer Genome Project database 
    08 김주연 Review of Cancer Genome Project database  
    08 김주연 Review of Cancer Genome Project database  
    08 김주연 Review of Cancer Genome Project database  
    15 박지혜 DrugBank 4.0 Update Review 

    2014-03:
    04 박지혜 Workflow of weighted drug score with kinetic parameter 
    11 백수연 Find module related to ADR class in 1000Genome individual 
    18 김주연 Role and mechanisms of drug targets, enzymes, transporters, and carriers 
    18 김주연 Role and mechanisms of drug targets, enzymes, transporters, and carriers 
    25 박지혜 Review : HumanCyc database  

    2014-02:
    04 백수연 Apply CCLE data to personal pharmacogenomics research 
    11 임재현 How SNP heterozygosity affects gene expressions 
    18 백수연 Research to find out ADR mechanism 

    2014-01:
    14 임재현 Quality check for exome sequence(COPD vs TCGA) 
    20 백수연 The Cancer Cell Line Encyclopedia (CCLE) - review and discussion about its personal pharmacogenomic application 
    28 박지혜 Pharmacokinetics - review of kinetic parameters 

    2013-12:
    03 이수연S review of Pharmacogenomics(Pharmacogenomics in Action) 
    17 민병주 Target CpG site enrichment method for methylation sequencing 
    24 서명의 Experimental methods for RNA sequencing 
    31 박지혜 Summary of exome sequencing processing pipeline 

    2013-11:
    05 백수연 The MedSeq Project : Integration of Whole Genome Sequencing into Clinical Medicine 

    2013-10:
    05 민병주 Genome sequencing for healthy individuals 
    15 서명의 Finding the lost factors in exome sequencing data 
    29 박지혜 Recent research trend of genetic variant scores 

    2013-09:
    03 백수연 Review and statistics of PharmGKB 
    10 임재현 current statistics for transcriptome reference : ensembl 
    23 이수연S current statistics for GWAS catalog 
    24 이수연S current statistics for GWAS catalog 

    2013-08:
    06 서명의 Analysis of epigenetic modification by bisulfite conversion 
    20 박지혜 Review of SIFT algorithm 

    2013-07:
    09 임재현 Potential etiologic and functional implications of genome-wide association loci for human disease and trait 
    09 임재현 Potential etiologic and functional implications of genome-wide association loci for human disease and trait 
    16 민병주 Genetic rearrangement induced by LCR block 
    27 서명의 CpG island analysis for personal genome interpretation 

    2013-06:
    04 서명의 Personal genome related DB review(4) - GWASdb 
    15 백수연 Personal genome related DB review(5) - Genevar 
    25 이수연S DB review(7) - Interpretome 

    2013-05:
    11 임재현 Personal genome related DB review(1) - SNPedia 
    14 이수연S Phenopedia and Genopedia 
    21 민병주 Personal genome related DB review(3) - SNP Nexus  
    21 민병주 Personal genome related DB review(3) - SNP Nexus  

    2013-04:
    06 임재현 COPD mRNA editing analysis scheme 
    13 이수연S dbGAP paper review 
    16 민병주 Methylation Analysis of 10 Lymphoma(MALT type) 
    27 서명의 case report of Target sequencing and its validation in 22 family 
    30 백수연 Review of eQTL analysis 

    2013-03:
    19 이수연S plan for team 
    26 백수연 Discussion application SNAP score on genome interpretation 

    2013-01:
    09 조용래 Development of gene-environment interaction database for personal genome interpretation 
    16 서희원 Called SNVs Comparison Between Two Platform Sequencing Techonologies and Promethease. 
    23 이수연S Risk prediction method & x-men 
    31 백수연 MedCassandra - apply for new snubi sequence 

    2012-12:
    12 이계화 AML-paired exome seqeuncing data analysis  
    26 임재현 Integration for Chip-Seq and RNA-seq data 

    2012-11:
    07 서희원 Blood genotyping for pretransfusion testing 
    14 백수연 Aplication of pharmacogenomic knowledge to clinic 
    21 강병희 Cancer Genomeancer (review for ICGC data portal) 

    2012-10:
    26 윤준희 Middle of report Genomancer 

    2012-09:
    08 임재현 Hypertension meta analysis  
    14 윤준희 Plan for Server-client communication. 
    14 조용래 Environmental Facter Viewer in Genomancer 
    18 윤준희 Updated plan for genomancer included server-client communication codes 
    26 임재현 Review for Encode(1) : An integrated encyclopedia of DNA elements in the human genome 
    26 조용래 Risk assessment for alcoholism 

    2012-08:
    01 백수연 Review of PharmGKB data open policy 
    03 윤준희 Overview of Genomancer test version 
    03 조용래 Development of gene-environment interaction database for personal genome interpretation 
    22 조용래 Meta analysis tool 
    29 조용래 Result of Meta Analysis 
    31 이수연S Meta analysis 1st result and plan for RP & x-man 
    31 윤준희 Overview of Genomancer test version and Demo 

    2012-07:
    04 조용래 Web Interface for Meta Analysis 
    04 이계화 Metaanalysis Plan for Obese X-men 
    05 조용래 Web Interface for Meta Analysis 
    11 이수연S Meta analysis plan  
    18 윤준희 Genomancer UI frame 
    20 윤준희 Genomancer discussion 
    25 서희원 Reads align with Bowtie2 

    2012-06:
    08 윤준희 Genomancer App version  
    08 이수연S Clinical prediction and X-men 
    08 조용래 Development of gene-environment interaction database for personal genome interpretation 
    13 임재현 Result of Pilot study for Genomancer Xman Sleep 
    20 윤준희 Overview of Genomancer modified design 
    29 조용래 Development of gene-environment interaction database for personal genome interpretation 

    2012-05:
    03 이수연S Clinical prediction and X-men 
    04 윤준희 Plan for Genomancer 
    04 조용래 Gene - Disease - Environment for personal genome interpretation 
    09 조용래 Development of gene-environment interaction database for personal genome interpretation 
    17 서희원 RNA-Seq Analysis pipeline and fastq quality control 
    18 조용래 Development of gene-environment interaction database for personal genome interpretation  
    23 임재현 Discussion meta-analysis process for risk assessment 

    2012-04:
    04 윤준희 Summary of pharmacogenomics 
    18 윤준희 Genomancer draft design 

    2012-03:
    14 윤준희 Summary of pharmacogenomic research 
    21 윤준희 naive results of 1000 genome analysis 
    27 김지훈 Summary and Overview of Personal Genome Deciphers team 
    27 정제균 향후 연구계획 논의 
    30 조용래 Development of gene-environment interaction database for personal genome interpretation 

    2012-02:
    01 서희원 Phenotypic signature practicality. 
    01 윤준희 PGSeminar presentation overview 
    01 조용래 Development of gene-environment interaction database for personal genome interpretation 
    08 조용래 Development of gene-environment interaction database for personal genome interpretation 
    08 권창혁 TCGA 2008 nature journal 
    15 조용래 Development of gene-environment interaction database for personal genome interpretation 

    2012-01:
    02 윤준희 Weekly progress 
    02 조용래 Environment and Disease Risks 
    11 서희원 Semantic Map for Phenotypic Signature 
    11 조용래 The development of priority weighting approach for disease-environment interaction based on personal genome 
    11 권창혁 COSMIC database parsing 
    18 서희원 SNUBI Sequence Preprocessing Final Report 
    18 윤선민 Algorithms to prioritize candidate genes underlying diseases 
    18 조용래 Introduction of MeSH and studies related to Gene-Environment 
    25 서희원 Personal Genome Seminar Preview: Establishing phenotypic signatures to infer relevant phenotypic characteristics using semantic similarity calculation. 
    25 윤선민 Interpreting personal genome variations using gene-disease-environment interaction network analysis 
    25 조용래 The Development of Priority Weighting Approach for Disease-Environment Interaction Based on Personal Genome 

    2011-12:
    13 서희원 Gene-set wise approach using KEGG databases 
    13 윤선민 Visualization of gene-disease-environment interaction network analysis 
    13 권창혁 Normal(1000Genome) to Cancer(CGP) 
    13 조용래 Genetic risk platform 
    21 조용래 Platform for estimation and visulization of personal disease risk prediction 
    21 윤준희 Plan for Pharmacogenomic phenotype 
    21 권창혁 Variant parsing of 1000 Genome data 
    28 윤준희 Finding Drug-Drug interaction using pharmacogenomic phenotype 
    28 서희원 Research in progress 
    28 윤선민 Future study for improvement 
    28 권창혁 1000 Genome data parsing 
    28 조용래 Structured Phenotype 

    2011-11:
    02 서희원 Construct a Network with Variants Information on Disease Network 
    02 윤준희 VAAST result 
    02 조용래 How to report for sequence analysis result 
    02 김지훈 Genetic risk reporting 
    08 서희원 Gene-set Wise Approach for Disease Susceptibility Genes on PubMed.    
    08 조용래 Geographic differences in allele frequencies of susceptibility SNPs for cardiovascular disease 
    16 윤준희 Poster overview 
    16 서희원 Gene-set wise approach using KEGG pathway.    
    16 조용래 HGDP(Human Genome Diversity Project) 
    16 윤선민 Problems of gene-disease-environment interaction network analysis 
    22 권창혁 Best Practice Variant Detection with the GATK v3 
    22 서희원 Phenotypic signature using genomic variant annotation on semantic network.  
    22 윤준희 Drug response phenotype standardization and SNP-phenotype reliability score 
    22 조용래 HuGE Navigator Localization 
    30 서희원 Genotype Look and Feel: Genome Data Mining for Phenotypic Signature. 
    30 조용래 Human Variome Project 

    2011-10:
    05 서희원 SNUBI Sequence Variants Analysis Pipeline and Visualization Tool 
    05 윤선민 Work process 
    05 조용래 Implementing risk prediction service 
    06 윤준희 Seminar review 
    12 윤선민 PG Seminar preview 
    12 윤준희 Pharmacogenomics annotation seminar review 
    12 조용래 Implementing risk prediction service 
    19 서희원 Unknown Variant Effect Imputation by Nearby Annotated Variants. 
    19 조용래 The Phenotype Standardization Project 
    26 윤준희 Unmapped variants analysis overview 

    2011-09:
    02 윤준희 PharmGKB annotation 
    02 윤선민 Gene-environment interaction 
    02 서희원 Visualization of variant annotation results 
    02 조용래 Genetic Risk Prediction 
    06 조용래 Genetic Risk Prediction 
    14 조용래 Genetic score(post-test prob) 
    14 윤준희 Future work 
    21 조용래 Mapping rsID, genotype for each disease 
    21 윤선민 Gene-environment interaction using 2011 data 
    28 윤준희 Future process and review in pharmacogenomics 
    28 조용래 Implementing risk prediction service 
    28 윤선민 patients statistics 

    2011-08:
    05 조용래 Atul Paper Replication 
    05 윤선민 Factors extraction for etiome replications 
    05 윤준희 SOAP2, SOAP 
    17 조용래 GDS, GPL Parsing 

    2011-07:
    01 윤준희 Alignment tools and LASTZ 
    04 윤준희 Pharmacogenetics analysis process 
    04 윤선민 Relationship between Disease and Etiological factors for deciphering Human genome 
    04 서희원 Assessment of overrepresented variant-set in rare disease associated genetic variants 
    22 서희원 SNUBI Sequences SIFT Analysis 
    29 서희원 Quick Look: Tabix    
    29 김지훈 Personal genome variants annotation 
    29 한현욱 introduction & installation of Galaxy LIMS 

    2011-06:
    03 서희원 File Formats for Genome 
    03 한현욱 Genetic Counseling & Service 
    10 서희원 SNP Set Enrichment Analysis Associations with Rare Variants 
    10 김지훈 Building SNP-Phenotype association database    
    10 윤선민 MEDLINE/PubMed Baseline Repository (MBR) 
    17 윤준희 Time Table 
    17 조용래 Replication Plan    
    21 서희원 SSEA Data Set from Publication    
    21 윤준희 LASTZ introduction, PharmGKB mapping strategy. 
    23 조용래 LANCET Replication Progress - Time schedule 

    2011-05:
    06 윤준희 Pharmaceutical Response in Personal Sequence 
    13 윤준희 Stepping toward Personalized Medicine in Personal Sequence 
    13 윤선민 Indentity evaluation 
    13 조용래 23andMe Review 
    21 서희원 Rare Disease Knowledgebase and Exome Sequence Data 
    27 윤선민 about etiome 
    27 조용래 Disease-associated SNP Database 
    27 윤선민 systemetic validation result of ADR gene detection 

    2011-04:
    08 정희준 discuss about integration of analysis result and biological knowledgebase 
    08 조용래 2011-04-08 Team NBA Meeting Report 
    15 조용래 Relication Design & Progess 
    15 윤선민 Individual topic paper outline 
    19 윤선민 simple idea for graduation paper 
    26 윤준희 Present situation of Personal Genome Research 

    2011-03:
    25 정희준 paper review about COSMIC, Oncomine 

    2010-12:
    29 정희준 a 

    2010-11:
    03 조용래 SVG in HTML5    
    04 윤선민 Paper Review for SNP data analysis 
    24 정희준 Concept of AXP 
    25 조용래 SVG 

    2010-10:
    20 정희준 ppt 
    27 윤선민 GWAS 
    31 윤선민 temp_seminar 

    2010-08:
    15 윤선민 Path Search 
    26 한현욱 gene2mesh 

    2010-07:
    01 정희준 summary 
    02 윤선민 GSEA, GWAS 
    08 한현욱 i-GWAS4GSEA 
    22 윤선민 PANTHER version 6 

    2010-06:
    03 정희준 AXPIII 
    03 윤선민 individual project research 
    10 정희준 Organization of AXP concept 
    10 한현욱 Replication of perturbation sensitivity 
    10 윤선민 Paper review process 
    17 한현욱 Additional thinking on perturbation sensitivity 
    17 윤선민 Human Disease-Drug Network 
    24 한현욱 progress of perturbation network analysis 
    3 한현욱 m-core, distribution of degree 

    2010-05:
    07 윤선민 data entries 
    27 윤선민 Syntactic Integration - PID 
    27 조용래 Extract Reactome Data 

    2010-04:
    01 윤선민 Datamodel of Reactome, PID and INOH 
    01 조용래 Pathway Structure comparison(KGML, BioPAX, Reactome, PID) 
    01 한현욱 metagraph 
    08 한현욱 PathwayStuio Review 
    08 조용래 Pathway Structure comparison(KGML, BioPAX, Reactome, PID, SBML) 
    08 윤선민 Comparison of Ontologies 
    15 조용래 Extracting Entry Data of Apoptosis from KGML, Reactome 
    15 한현욱 Requriement Analysis of Pathway Systems_revision 
    15 윤선민 Comparison of Melecule Role Ontologies 
    17 한현욱 Requriement Analysis of Pathway Systems_revision II 
    19 조용래 HPD: an online integrated human pathway database enabling systems biology studies 
    22 조용래 How to consist of entries extracted from pathway DBs. 
    22 윤선민 the Event Ontology & How to extract info using Kegg API 
    28 한현욱 ArrayXPathIII Database Schema 
    29 조용래 The ArrayXPathIII Database Schema Ver1.0 
    29 한현욱 OMIM gene pathway interaction 

    2010-03:
    01 조용래 Meta Path Review 
    01 윤선민 KEGG API 
    04 조용래 Modeling Comparison ver2 
    04 윤선민 KGML 
    11 조용래 Pathway Models Review 
    11 윤선민 reactome 
    11 한현욱 Thetharus Vs KEGG classification 
    12 조용래 Pathway Models Review 
    18 조용래 Pathway Structure Comparison 
    18 윤선민 Reactome model and comparison with NCI PID 
    21 조용래 Pathway Structure comparison(KGML, BioPAX, Reactome) 
    25 조용래 Pathway Structure comparison(KGML, BioPAX, Reactome) 
    25 윤선민 INTERACTION PATHWAY DATABASE 
    25 한현욱 Visualizing biological pathways 

    2010-02:
    04 윤선민 Enrichment study with data 
    04 정희준 Killer application 
    04 조용래 The systems biology graphical notation review(progress) complement 
    11 윤선민 GSEA & MEA 
    11 정희준 PathComp 
    11 조용래 KGML(KEGG Markup Language)_ver2 
    18 정희준 pahtcomp 
    18 윤선민 Analysis & KGML 
    18 조용래 The Regulation of Gene Expression 
    25 윤선민 Network Analysis 
    25 조용래 KGML vs BioPAX 

    2010-01:
    15 윤선민 Enrichment Analysis 
    15 조용래 Visualization Tools inquiry and improvement(ver.3) 
    15 정희준 Network analysis 
    21 윤선민 advanced Enrichment Analysis 
    21 조용래 ArrayXPath3 Interface & Visualization 
    28 윤선민 statistics 
    28 조용래 ArrayXPath3 Interface Renewal 

    2006-07:
    06 정희준 ArrayXPath: map on homologene    
    06 김민구 Another ANOVA viwer in BioCANDI [biocandi]
    13 정태수 Issues on PathTalk 

    2006-06:
    01 김지훈 similarity among normal tissues and cancer by biological context 
    01 정용 Interim report of clustering columns in GEO data table : Platform [Technology type, GEO, data column]
    08 한미령 Meta analysis using AB chip & cDNA chip 
    08 정희준 CellMAP progrerss 
    15 박찬희 HDF 가 우리에게 유용한가? 
    15 김민구 A Primer on Kernel Methods [kernel]
    22 정태수 Issues on PathTalk [pathtalk, kernel]   
    22 김지훈 Lattice similarity work progress [biolattice]
    29 정용 Remaking extended schemata & result of mapping to primary schema [in situ oligo, mappping result, GEO]

    2006-05:
    04 정태수 [PathTalk] Geodesic distance in pathway graph [PathTalk]
    04 김지훈 Similarity measure between lattices : toxicant data [BioLattice]
    11 김민구 Correlation dependent on third gene expression level 
    11 한미령 Multimarker predictive model using machine learning algorithm 
    18 정희준 CellMap for pathway [pathway map, integration of GO and pathway]
    18 정용 Approach of Clustering columns in GEO data table : Platform [technology type, data column, platform, sample, GEO]
    25 박찬희 약물유전체 DB 수정요구사항 정리 
    25 정태수 PathTalks - reasearch plan [PathTalks]

    2006-04:
    06 정희준 Pathway mapping 
    13 김민구 Temporal relation between GO 
    20 한미령 Multimarker predictive model using machine learning algorithm 
    20 정태수 BioLattice: similarity of lattices [BioLattice]
    27 박찬희 Depth-First Search 기반 Object Search & Drawing Object Network 
    27 정용 Difficulty in importing GEO data into Xperanto 

    2006-03:
    03 정태수 Visualization and evaluation of structural relationship between gene clusters and biological pathways [PathTalk]
    03 정용 GEO, for better approach 
    09 박찬희 DB Update 및 Interface 현황 
    09 정희준 PathMeSH + miRNA progress 
    16 김지훈 BioLattice application II 
    16 김민구 Functional enrichment of sequential pattern with MIPS functional category 
    23 한미령 Integrating Classification and Association Rule Mining 
    30 정태수 Geodesic distance in pathway graph 
    30 정용 Present state of GEO Localization 

    2006-02:
    03 정태수 PathTalk: Visualization and evaluation of structural relationship between gene clusters and biological pathways [PathTalk]
    10 한미령 Applying rule mining and FCA to protein with profile & pattern 
    10 김지훈 Rule mining from concept lattice 
    24 한미령 Association Mining and Formal Concept Analysis 

    2006-01:
    06 김민구 Application of Genetic Algorithm to sequential pattern mining on gene expression data 
    06 한미령 Comparative analysis of array CGH algorithms 
    13 정태수 PathTalk: diameters of gene sets on topological structure of pathways [PathTalk]
    13 정희준 ArrayXPathIII: Implementation of Mutual Information 
    20 김지훈 Rule mining from Concept Lattice 
    20 김민구 Sequential pattern mining의 명확한 논리전개를 위한 flow chart 

    2005-12:
    02 김지훈 Genome Annotation Report 
    02 한미령 유방암 AB chip 분석계획 
    16 김미현 Evaluation of matrix factorization methods for the analysis of DNA microarray gene expression data 
    16 김민구 Rationale for sequential pattern mining 
    23 정태수 PathTalk: Visualization and evaluation of structural relationship between gene clusters and biological pathways [PathTalk]
    23 정희준 ArrayXPathIII: localize KEGG pathways using KEGG API 
    30 김지훈 Orientia genome annotation update 

    2005-11:
    04 김민구 spm의 설득력있는 논리전개 
    11 한미령 Plan for protein-ontology lattice 
    18 김미현 matrix factorization for clustering and pattern discovery 정리 
    25 정태수 DispLay: different sequential patterned moduLes in array data [DiffCoexpression]
    25 정희준 Plan for ArrayXPath and add a function 

    2005-10:
    07 김지훈 research plan 
    07 박찬희 약물유전체 DB 수정 사항 
    14 한미령 What is the next step? 
    21 김미현 (progress) Matrix factorization for clustering and molecular pattern discovery on Microarray 
    21 정태수 Kullback-Leibler divergence to measure the biological relevance of given cluster 
    28 정희준 Idea for ArrayXPath III 
    28 김지훈 correlation of transcriptome and interactome 

    2005-09:
    02 정태수 세포의 미생물 오염 안전성 평가 
    09 정희준 Frame work of GRIP 
    09 김지훈 Short BioLattice Manuscript 
    16 박찬희 GRIP Pathway Mapping 
    16 김민구 Cluster viewer upgrade 
    23 김미현 Matrix factorization fo microarray data analysis 
    23 한미령 aCGH_GLAD 
    30 정희준 Idea of pathway merge 

    2005-08:
    05 김민구 Get the facts about SGD GO-slim 
    05 한미령 Molecule Role Ontology 
    12 정태수 Required analysis modules in Xperanto 
    12 김지훈 BioLattice manuscript (artworks) 
    19 정희준 newGRIP manuscript 
    19 김민구 The very first step in mouse lymphoma microarray analysis 
    26 김미현 Issues for application MF to microarray data analysis 

    2005-07:
    01 김민구 Temporal relation between GO terms 
    08 한미령 Further steps for protein classification 
    08 정태수 Filters in Xperanto-BioCANDI 
    15 김미현 Review of Matrix factorization (ICA와 비교) 
    15 윤혜성 Heterogeneous Ensemble 
    22 정희준 Chip2Chip 
    29 정희준 Biological mode and knowledge based conversion for microarray 
    29 김옥구 PhactaX의 SOAP 기반 임상시험관련 자료교환 

    2005-06:
    03 윤혜성 Cluster Ensemble and Its Applications in Gene Expression Analysis 
    03 정태수 Learning Model for pathway extension 
    10 정희준 Summary GRIP concept for manuscript 
    10 김지훈 Biological interpretation of BioLattice results 
    17 박찬희 attributes of New GRIP 
    17 김옥구 Microarray Analysis Component 간 자료표현 XML Schema 개발 

    2005-05:
    06 정희준 Item sets for newGRIP 
    06 김지훈 Representation and visualization of cluster relationship 
    13 박찬희 Gene 레벨 & Gene Family 레벨 진행상황 
    13 김옥구 Microarray Analysis Component 간 자료표현 및 교환방법 
    20 한미령 Protein classification from protein domain composition and GO using formal concept analysis 
    27 김미현 review of issues for ICA 

    2005-04:
    01 정태수 RunDEDS 
    01 정희준 PathCross: the first step 
    08 김지훈 BioLattice analysis results 
    08 박찬희 Current Localized Sequence object status 
    15 김옥구 Development plan for the component-based Microarray analysis environment 
    15 김민구 Summary of sequential pattern mining 
    22 한미령 Analysis & interpretation of tripartite lattice 
    22 김미현 Web-DEDS 보완 
    29 윤혜성 Combining Multiple Clusterings 
    29 정태수 Plan to complete PathPlus [pathplus]

    2005-03:
    03 정희준 Manuscript for AXP 2.0 
    03 김지훈 BioLattice work report 
    10 박찬희 GRIP Specs. (미정리..) 
    10 김옥구 Microarray High-Level Data Analysis Modeling (Use Case Modeling) 
    17 김민구 FESD: a Functional Element SNPs Database in human 
    17 한미령 Database localization & How to make matrix? 
    24 김미현 Progress in DEDS 
    24 윤혜성 Approaches to Discover Emerging Patterns in bio-data 

    2005-02:
    03 김지훈 Supporting evidence to modular organization 
    03 김민구 Current agenda and Overlap matrix visualization 
    17 한미령 Three-way interpenetration among protein domain, protein, and GO using FCA 
    24 김미현 Algorithm of ICA - FastICA 
    24 윤혜성 Application of emerging patterns for multi-source data classification and analysis 

    2005-01:
    06 박찬희 MDS errors... 
    06 김민구 Manuscripting sequential patterning mining in gene expression data 
    13 정희준 The development present status of ArrayXPath 2.0 
    13 김미현 Algorithm of ICA 
    20 한미령 GOTree Machine (GOTM) 
    20 박찬희 GRIP object 
    27 한미령 Review GO tool 
    27 김옥구 MAGE-OM 내 Highlevel Data Analysis 패키지 확장 
    27 정희준 Strategy for ArrayXPath 

    2004-12:
    02 정희준 ArrayXPath plan for NGIC project 
    02 김지훈 GO-FCA work progress 
    09 김옥구 임상시험자료관리시스템 내 MGED 모델링 자료수집 
    09 한미령 VitaPad: Visualization Tools for the Analysis of Pathway Data 
    16 김민구 Sequential pattern mining에 대한 기본개념과 테크닉들 
    16 박찬희 GRIP Object 의 property 결정 
    23 김미현 Estimating gene networks Using Bayesian network 
    23 정희준 Items of ArrayXPath 2.0 
    30 김지훈 Progress note for BioLattice 
    30 김옥구 임상시험자료관리시스템 내 MGED 자료 입력설계 

    2004-11:
    04 정희준 ArrayXPath: version 2.0 
    04 김지훈 GO-based cluster annotation using Formal Concept Analysis 
    11 김민구 Relevant work review of k-gOPSM 
    11 김옥구 임상시험자료와 생물실험자료의 연결방안 
    18 정태수 CGH-Explorer 및 유사 툴 리뷰 
    18 박찬희 GRIP Version 2 Intro
    ( GRIP Ver.2 의 modelling 과 open/closed integration issue 들에 대한 논의 )     
    25 한미령 Searching pathway databases 
    25 김미현 Using BN for estimating gene networks from microarrays and biological knowledge 

    2004-10:
    07 김민구 Order-based subspace clustering 
    07 김옥구 임상시험자료와 바이오자료의 통합을 위한 데이터 모델 
    14 정태수 Determining differentially expressed genes in a microarray expression dataset 
    14 박찬희 GEO에서 Platform Description header 와 Sample Description header의 분석 
    21 한미령 Possibility of systematic Multiple-pathways 
    21 김미현 Bayesian Network & example of application 

    2004-09:
    23 정희준 PathMesh - Writing manuscript - 
    23 김지훈 Total context view of clusters using FCA 

    powered by SNUBI